Skip to content
Disclosery

FCPM III SERVICES B.V.

Follow

13F filer, CIK 2013410, NAARDEN, Netherlands

FCPM III SERVICES B.V. reported $369,155,175 across 8 holdings for the quarter ended 2025-06-30, in a 13F-HR filed 2025-08-14.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000950123-25-008060

Period
2025-06-30
Reported value
$369M
Holdings
8
Top 10 weight
100%
New
1
Sold out
0

Part of the filer group FCPM III SERVICES B.V.

How groups are built

Largest buys vs the previous quarter

SecurityShares changeApprox. value
RAPTnew+440,176$3.45M
ASTRIA THERAPEUTICS INCadded+285,000$1.62M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
NAMSreduced-303,197-$5.49M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2025

Share positions as resolved from 13F-HR 0000950123-25-008060, largest first. % of portfolio is the value over $369,155,175, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
NAMSNEWAMSTERDAM PHARMA COMPANYQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 11,831,461 shares; 2024Q4: 10,597,181 shares; 2025Q1: 10,935,310 shares; 2025Q2: 10,632,113 shares 10,632,113$193M52.16%-303,197Timeline
DYNDYNE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 5,954,069 shares; 2024Q4: 5,462,846 shares; 2025Q1: 5,462,846 shares; 2025Q2: 5,462,846 shares 5,462,846$52M14.09%0Timeline
REPLREPLIMUNE GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 4,866,449 shares; 2024Q4: 3,970,668 shares; 2025Q1: 3,909,696 shares; 2025Q2: 3,909,696 shares 3,909,696$36.3M9.84%0Timeline
ENGNENGENE HOLDINGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 8,677,951 shares; 2024Q4: 9,632,561 shares; 2025Q1: 9,632,561 shares; 2025Q2: 9,632,561 shares 9,632,561$35.1M9.5%0Timeline
BCYCBICYCLE THERAPEUTICS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 2,339,961 shares; 2024Q4: 3,452,330 shares; 2025Q1: 3,452,330 shares; 2025Q2: 3,452,330 shares 3,452,330$24M6.5%0Timeline
ASTRIA THERAPEUTICS INCASTRIA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 2,872,537 shares; 2025Q1: 3,822,537 shares; 2025Q2: 4,107,537 shares 4,107,537$23.4M6.34%+285,000
RAPTRAPT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 440,176 shares 440,176$3.45M0.93%newTimeline
ENGNWENGENE HOLDINGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 2,878,148 shares; 2024Q4: 2,878,148 shares; 2025Q1: 2,878,148 shares; 2025Q2: 2,878,148 shares 2,878,148$2.36M0.64%0Timeline

How Q2 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0000950123-25-008060 base2025-08-14acceptance time not in the bulk data set